Gérard Zalcman - Researcher Profile

Publications

2 shown

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi , Julien Mazières , David Planchard +27 more

2015 The Lancet Oncology 1406 citations

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

David Montani , Emmanuel Bergot , Sven Günther +19 more

Background— The French pulmonary hypertension (PH) registry allows the survey of epidemiological trends. Isolated cases of precapillary PH have been reported in patients who hav...

2012 Circulation 626 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,032
Institution: Centre Hospitalier Universitaire de Caen Normandie

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0343-9575

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.